Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia Presents Study Results On New Artificial Intelligence That Predicts Diagnostic Concordance For Melanoma

Proscia
By Author Proscia | November 1, 2022

Conducted at the University of Florida and Thomas Jefferson University, Proscia’s retrospective study “Using Whole Slide Image Representations from Self-Supervised Contrastive Learning for Melanoma Concordance Regression” demonstrated the AI’s performance on 1,412 whole slide images of skin biopsies.

Our website uses cookies. By using this site, you agree to its use of cookies.